←
Scott Dehm367 posts
Scott Dehm avatar

Scott Dehm

@scottdehm

Professor @UMNcancer studying steroid hormones, androgen receptors, and #ProstateCancer genomes. Apogee Enterprises Chair in Cancer Research . Views=mine.

◷ Joined May 2011▧ 23 Photos and videos
Prostate Cell News avatar
⟳ Scott Dehm retweeted
Prostate Cell News@ProstateCell·Jan 27

Today in @CCR_AACR! 🖨️ 🔥 Dr. @scottdehm led this study showing that androgen receptor (AR) alterations in ctDNA accumulate at progression in mCRPC patients treated with AR pathway inhibitors, especially in those with initially durable responses. bit.ly/49Iamij

Post attachment
Luke Selth avatar
⟳ Scott Dehm retweeted
Luke Selth@LukeSelth·14 Apr 2025

Check out our new work exploring AR biology in advanced prostate cancer: tinyurl.com/2s39jh8b. We found that tumours expressing a specific AR variant (ARv567es) have a distinct transcriptomic profile and are resistant to androgen deprivation and bipolar androgen therapy

Scott Dehm avatar
Scott Dehm@scottdehm·7 Feb 2025

KLF5 was identified as the transcription factor that supports these transcriptional features. Defining DNPC by what "it is" (a hybrid basal/club/hillock phenotype), instead of what "it's not" (negative for AR and neuroendocrine features) may aid development of new therapies.

Scott Dehm avatar
Scott Dehm@scottdehm·7 Feb 2025

We found that the double-negative phenotype of castration-resistant prostate cancer (a.k.a. "DNPC") exhibits the same transcriptional features that define basal, club, and hillock epithelial cells of the benign prostate.

Josh Lang avatar
⟳ Scott Dehm retweeted
Josh Lang@JoshLangMD·6 Feb 2025

Thrilled to share a project that we envisioned over a decade ago to perform high purity/high specificity molecular analysis of circulating tumor cells! Led by the brilliant @marina_sharifi and @JSperger @AACR Funded by @PCF_Science @NIH @CDMRP

Now online in @CD_AACR: High-Purity Circulating Tumor Cell RNA Sequencing Identifies #ProstateCancer Lineage Phenotypes Prognostic for Clinical Outcomes - by @marina_sharifi, @JSperger, Shuang Zhao, @JoshLangMD et al. doi.org/10.1158/2159-8290.CD… @UWCarbone @UWMadison #LiquidBiopsy

Post attachment
Scott Dehm avatar
Scott Dehm@scottdehm·24 Jan 2025

Excited to share a new paper by postdoc Dr. Kiel Tietz @UMNCancer! CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells: Cell Reports cell.com/cell-reports/fullte… Work funded by @CDMRP and @NCICancerBio